Telix Pharmaceuticals Limited (TLX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 494.79M | 610.67M | 918.56M | 255.26M | 224.85M | 219.29M | 173.23M | 149.5M | 47.54M | 70.31M | 93.63M | 44M |
| Cash & Short-Term Investments | 212.53M | 317.84M | 710.35M | 118.84M | 123.24M | 131.73M | 116.33M | 122.61M | 22.04M | 49.62M | 77.94M | 24.38M |
| Cash Only | 212.53M | 317.84M | 710.35M | 118.84M | 123.24M | 131.73M | 116.33M | 122.61M | 22.04M | 49.62M | 77.94M | 24.38M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 207.29M | 198.73M | 158.99M | 97.27M | 64.78M | 64.53M | 39.35M | 16.91M | 19.42M | 365K | 12.4M | 17.42M |
| Days Sales Outstanding | 29.86 | 27.52 | 19.68 | 39.13 | 20.94 | 21.46 | 18.87 | 68.93 | 192.64 | 200.12 | 377.3 | 837.32 |
| Inventory | 55.55M | 54.05M | 38.14M | 30.8M | 17.31M | 12.6M | 8.48M | 6.53M | 3.45M | 889K | 633K | 446K |
| Days Inventory Outstanding | 17.07 | 13.8 | 15.09 | 33.73 | 23.64 | 7.4 | 7.51 | 11.5 | 8.42 | 4.93 | 4.15 | 4.41 |
| Other Current Assets | 0 | 40.05M | 0 | 8.35M | 7.1M | 10.43M | 6.57M | 3.44M | 1.43M | 19.44M | 1.79M | 1.76M |
| Total Non-Current Assets | 1.28B | 1.22B | 597.87M | 490.7M | 173.45M | 91.04M | 87.36M | 66.45M | 62.27M | 58.54M | 70.81M | 55.01M |
| Property, Plant & Equipment | 173.2M | 113.81M | 54.32M | 38.26M | 30.49M | 23.09M | 18.84M | 8.49M | 6.33M | 4.58M | 4.82M | 5.08M |
| Fixed Asset Turnover | 4.32x | 7.06x | 12.84x | 5.50x | 10.52x | 10.54x | 9.96x | 3.25x | 0.86x | 0.62x | 0.73x | 0.46x |
| Goodwill | 298.1M | 285.08M | 106.65M | 117.75M | 4.85M | 5.55M | 5.52M | 4.09M | 4.1M | 4.17M | 4.22M | 4.22M |
| Intangible Assets | 590M | 611.2M | 309.49M | 188.16M | 104.82M | 58.83M | 58.98M | 57.68M | 55.73M | 53.77M | 59.19M | 44.61M |
| Long-Term Investments | 55.57M | 6.22M | 6.09M | 10.46M | 12.26M | -5.55M | -5.52M | 0 | 0 | 183K | -4.22M | 175K |
| Other Non-Current Assets | 43.18M | 82.48M | 74.58M | 287.54M | 586K | 450K | 327K | -3.81M | -3.88M | -58.35M | 183K | -4.22M |
| Total Assets | 1.77B | 1.83B | 1.52B | 745.96M | 398.3M | 310.34M | 255.35M | 215.94M | 109.81M | 128.84M | 157.82M | 93.86M |
| Asset Turnover | 0.35x | 0.35x | 0.53x | 0.33x | 0.80x | 0.78x | 0.58x | 0.15x | 0.04x | 0.02x | 0.03x | 0.02x |
| Asset Growth % | 16.78% | 144.75% | 280.72% | 140.37% | 55.98% | 43.71% | 132.53% | 67.6% | -30.42% | 37.27% | 53.81% | 43.31% |
| Total Current Liabilities | 347M | 458.11M | 330.91M | 258.37M | 157.41M | 142.63M | 85.56M | 46.55M | 37.98M | 22.29M | 19.96M | 10.18M |
| Accounts Payable | 107.36M | 79.3M | 68.7M | 22.31M | 32.84M | 58.69M | 16.81M | 20.16M | 11.88M | 11.14M | 5.81M | 5.16M |
| Days Payables Outstanding | 29.06 | 22.16 | 19.92 | 38.66 | 72.33 | 26.49 | 18.5 | 36.9 | 44.63 | 54.91 | 42.21 | 54.08 |
| Short-Term Debt | 19.64M | 19.48M | 18.99M | 1.9M | 964K | 851K | 636.24K | 555K | 19K | 552K | 264K | 925K |
| Deferred Revenue (Current) | 17.18M | 6.75M | 11.25M | 12.38M | 10.99M | 8.36M | 3.35M | 10.24M | 6.14M | 3.04M | 3.23M | 0 |
| Other Current Liabilities | 99.6M | 134.73M | 109.67M | 150.02M | 44.47M | 44.57M | 23.04M | 19.01M | 7.66M | 6.17M | 5.06M | 1.38M |
| Current Ratio | 1.43x | 1.33x | 2.78x | 0.99x | 1.43x | 1.54x | 2.02x | 3.21x | 1.25x | 3.15x | 4.69x | 4.32x |
| Quick Ratio | 1.27x | 1.22x | 2.66x | 0.87x | 1.32x | 1.45x | 1.93x | 3.07x | 1.16x | 3.11x | 4.66x | 4.28x |
| Cash Conversion Cycle | 17.86 | 19.16 | 14.85 | 34.2 | -27.75 | 2.37 | 7.88 | 43.53 | 156.43 | 150.14 | 339.24 | 787.65 |
| Total Non-Current Liabilities | 801.64M | 720.24M | 617.31M | 83.61M | 91.98M | 91.65M | 92.88M | 63.99M | 68.19M | 57.57M | 64.49M | 29.96M |
| Long-Term Debt | 587.13M | 569.95M | 551.82M | 9.95M | 8.21M | 5.57M | 3.31M | 2.01M | 0 | 1.14M | 95K | 127K |
| Capital Lease Obligations | 84.69M | 39.45M | 8.14M | 8.41M | 7.68M | -6.68M | 6.49M | 2.01M | 1.91M | 1.14M | 1.34M | 535.47K |
| Deferred Tax Liabilities | 94.12M | 60.13M | 9.38M | 0 | 3.92M | 0 | 5.24M | 0 | 0 | 0 | 6.62M | 0 |
| Other Non-Current Liabilities | 35.7M | 49.15M | 44.67M | 65.27M | 60.02M | 79.4M | 79.98M | 61.98M | 67.77M | 27.99M | 57.41M | 29.29M |
| Total Liabilities | 1.15B | 1.18B | 948.22M | 341.98M | 249.39M | 234.28M | 175.35M | 110.53M | 107.66M | 80.91M | 78.81M | 40.14M |
| Total Debt | 699.77M | 641.72M | 581.45M | 22.14M | 17.45M | 13.1M | 10.45M | 2.57M | 2.54M | 1.7M | 2.21M | 3.08M |
| Net Debt | 487.24M | 323.88M | -128.9M | -96.69M | -105.79M | -118.63M | -105.88M | -120.04M | -19.5M | -47.92M | -75.74M | -21.3M |
| Debt / Equity | 1.12x | 0.99x | 1.02x | 0.05x | 0.12x | 0.17x | 0.13x | 0.02x | 1.18x | 0.04x | 0.03x | 0.06x |
| Debt / EBITDA | 25.25x | 24.26x | 8.00x | 1.27x | - | 0.38x | - | - | - | - | - | - |
| Net Debt / EBITDA | 17.58x | 12.24x | -1.77x | -5.55x | - | -3.42x | - | - | - | - | - | - |
| Interest Coverage | 0.94x | -0.45x | 4.75x | 7.41x | 35.04x | -26.83x | -103.18x | -511.34x | -595.09x | -431.67x | -36.40x | -105.79x |
| Total Equity | 622.27M | 647.38M | 568.21M | 403.97M | 148.91M | 76.06M | 80.01M | 105.41M | 2.16M | 47.93M | 79.02M | 53.72M |
| Equity Growth % | 9.51% | 60.25% | 281.58% | 431.15% | 86.12% | -27.85% | 3607.46% | 119.92% | -97.27% | -10.78% | 12.75% | 24.36% |
| Book Value per Share | 1.84 | 1.92 | 1.65 | 1.15 | 0.46 | 0.24 | 0.25 | 0.34 | 0.01 | 0.17 | 0.30 | 0.21 |
| Total Shareholders' Equity | 622.27M | 647.38M | 568.21M | 403.97M | 148.91M | 76.06M | 80.01M | 105.41M | 2.16M | 47.93M | 79.02M | 53.72M |
| Common Stock | 719.03M | 473.11M | 596.78M | 587.41M | 446.27M | 391.9M | 370.97M | 344.11M | 170.84M | 167.91M | 167.06M | 116.36M |
| Retained Earnings | -231.51M | -231.65M | -212.96M | -233.5M | -263.67M | -285.22M | -272.81M | -244.36M | -173.47M | -125.47M | -92.96M | -66.38M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 134.76M | 153.14M | 184.4M | 50.07M | -33.69M | -30.62M | -18.15M | 5.66M | 4.79M | 5.5M | 4.92M | 3.73M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |